Dr. Mark Joseph Torres, MD
General Practice
7+
Years in Practice
Practice Locations
3 locations
About Dr. Mark Joseph Torres
Mark Joseph Torres, MD is a healthcare provider.
Specialty Definition
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
7
Years Experience
3
Locations
2
States Licensed
Credentials & Board Certifications
Additional Specialties
Primary Specialty
General PracticeCredentials verified via NPI Registry (NPPES)
Education & Training
Medical School
University Of Washington School Of Medicine
Class of 2019
Licenses & Practice States
Licensed in 2 states
| State | License | Classification | Primary |
|---|---|---|---|
| — | Student in an Organized Health Care Education/Training Program | — | |
| Texas | T7378 | Internal Medicine |
Public Data Summary for Dr. Mark Joseph Torres
In their first decade of practice, Dr. Mark Joseph Torres represents the newer generation of general practice providers, MD, after earning their medical degree at University Of Washington School Of Medicine in 2019. Dr. currently practices across 3 facilities, including Ut Physicians in Houston, Texas. Their National Provider Identifier (NPI) is 1568025708, and the profile below combines data from CMS NPPES, Medicare billing records, the HHS OIG exclusion list, and — where available — CMS Open Payments, Medicare Utilization, and Part D prescriber summaries.
CMS Medicare data shows Dr. Mark Joseph Torres as a lower-volume general practice provider, treating approximately 23 Medicare beneficiaries and delivering 23 services in the most recent reporting year. That panel size indicates a smaller, more selective practice pattern.
Under the Physician Payments Sunshine Act, CMS reports that Dr. Mark Joseph Torres received $108 in industry payments in 2023. Payments at this scale are typical for most practicing physicians and generally reflect routine educational activities.
Transparency & Safety
Public records from CMS and OIG databases
Industry Payments
$108
Total payments received from pharmaceutical and medical device companies in 2023.
Source: CMS Open Payments (Sunshine Act)
Opioid Prescribing
This provider has no opioid prescriptions on file in Medicare Part D data.
Insurance & Accessibility
Reviews
Community reviews for Dr. Mark Joseph Torres
--
0 reviews
General Practice Providers Nearby
Same primary specialty near ZIP 77026
FAQ
Frequently asked questions about Dr. Mark Joseph Torres
What does Dr. Mark Joseph Torres specialize in?
Dr. Mark Joseph Torres specializes in General Practice. Secondary taxonomy filings also list Student In An Organized Health Care Education/training Program.
Where does Dr. Mark Joseph Torres practice?
Dr. Mark Joseph Torres practices at Ut Physicians in Houston, Texas. Dr. is also affiliated with 2 additional facilities, listed below.
Does Dr. Mark Joseph Torres accept Medicare?
CMS records show that Dr. Mark Joseph Torres accepts Medicare assignment. CMS billing data shows 23 Medicare beneficiaries treated in the most recent reporting year.
What is Dr. Mark Joseph Torres's NPI number?
Dr. Mark Joseph Torres's National Provider Identifier (NPI) is 1568025708. This is the unique 10-digit number the Centers for Medicare & Medicaid Services assigns to every practicing US healthcare provider. You can verify this number directly at the NPPES NPI Registry.
How long has Dr. Mark Joseph Torres been practicing?
Dr. Mark Joseph Torres has approximately 7 years of practice experience, having graduated from University Of Washington School Of Medicine in 2019.